← Leaderboards
Andrew H Ko
University Of California, San Francisco
$1,208,107
Attributed
$1,208,107
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.9K · FY2011–19$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,208,107 · 2
By mechanism
R21$604,315 · 1
P30$603,792 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Eric Collisson$14,159,893
- Trever G Bivona$22,714,857
- Ruth Dubin$4,143,897
- Charles Langelier$4,048,645
- Andrew Vaughan$5,293,800
Others in their field
Top investigators on “Protocols Documentation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$562,015,656
- Lawrence Corey · Fred Hutchinson Cancer Center$498,533,651
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$445,196,577
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$381,639,813
Research focus
Protocols DocumentationMonitorResearch DesignCaringSiteClinical ProtocolsResearch SupportAdjudicateCancer Center Support GrantResearch Project GrantsAuthorityInnovationBiometryClinical ResearchPublic HealthEnsureReview CommitteeCell LineCell CountBloodCytokeratinCancer Therapy Evaluation ProgramBiopsyArchives
Grant awards (7)
Protocol Review and Monitoring System$290,890
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$290,058
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$10,742
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$8,603
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$3,499
P30 · FY2018 · CA · contact PI
Dual Targeting of MEK and EGFR Signaling Pathways in Advanced Pancreatic Cancer$294,048
R21 · FY2012 · CA · contact PI
Dual Targeting of MEK and EGFR Signaling Pathways in Advanced Pancreatic Cancer$310,267
R21 · FY2011 · CA · contact PI